COPD Research Studies are enrolling now.
Those who qualify may receive*:
Plus, no cost to you.
No health insurance or referral needed.
For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.
Chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema, is a long-term lung disease that makes it hard for you to breathe. Most people with COPD have a little bit of both chronic bronchitis or emphysema, but usually have more of one condition. The symptoms include shortness of breath, a chronic cough often with a lot of mucus, frequent respiratory infections, fatigue, and wheezing.
COPD can be treated, but some people still experience flareups despite stable therapy. More research is needed so better treatment options can be available for people with COPD in the future.
Take the next step to see if you qualify for local research studies for people with COPD. But don’t delay — space is limited!
Tell us a little bit about yourself
Answer some questions about your health
We will connect you to available studies in your area
AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.